Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?
Cazzola
M
M
Matera
M G
MG
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D016896:Treatment Outcome
D000318:Adrenergic beta-Agonists; D018680:Cholinergic Antagonists